Connect with us

Hi, what are you looking for?

Monday, Jul 4, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Industry update

Organigram shares surge on big tobacco deal

British American Tobacco to invest $221M in the Canadian producer to develop new innovative weed and CBD products

Organigram shares surge on big tobacco partnership deal
Organigram shares surge on big tobacco partnership deal

Shares of OrganiGram Holdings Inc. (TSX: OGI) jumped 40 per cent Thursday after the cannabis producer said a subsidiary of one of the world’s largest tobacco firms purchased a 19.9 per cent stake in its business.

The New Brunswick-based company says its deal with British American Tobacco is worth around $221 million, marking the latest big tie-up with a major consumer-packaged-goods firm in the Canadian cannabis sector.

BAT, which sells Camel and Lucky Strike cigarettes as well as Vype nicotine vapour products internationally, will buy 58.3 million Organigram shares at a price of $3.79 per share. The share price was determined based on a five-day volume weighted average price on the Toronto Stock Exchange ending March 9, according to a statement.

CEO Greg Engel said Organigram had been looking for a strategic partner in the CPG space for a while, and BAT’s offer fit at the right time.

With the significant capital injection, the company says it’s better positioned to expand into the United States upon federal legalization.

It plans to develop new innovative cannabis products in collaboration with BAT with an initial focus on CBD, according to a statement. Once the deal closes, Organigram will have about $296 million in cash to fuel expansion efforts in Canada and internationally.

Read more: Organigram shares sink as sales shrink

Organigram shares surge on big tobacco partnership deal

British American Tobacco, founded in 1902, has been encouraging people who smoke cigarettes to switch to reduced-risk alternatives like its Vype vapour products. Press photo

The two firms agreed to create a “centre of excellence” to develop the new products. The operations will be set up at Organigram’s indoor facility in Moncton, and both firms will contribute scientists, researchers and product developers. BAT will also be entitled to add two members to Organigram’s board.

“We have been extremely selective about aligning with a strategic partner and, in BAT, we’ve found a leading consumer goods business with sophisticated management, innovative product platforms, an impressive dedication to research and development, deep consumer insights, regulatory expertise and a commitment to responsible stewardship and consumer safety among many other enviable attributes,” Engel said in a statement.

This isn’t the first time a large Canadian cannabis producer signed a deal with a major tobacco or big beverage company.

In 2018, Marlboro cigarettes maker Altria Group Inc. (NYSE: MO) bought a 45-per-cent stake in Cronos Group (TSX and NYSE: CRON) for $2.4 billion. Imperial Brands (LSE: IMB) invested $123 million into Auxly Cannabis Group Inc. (TSXV: XLY) (OTCQX: CBWTF) in July 2019.

And most notably, alcohol giant Constellation Brands (NYSE: STZ) was the first major blue-chip company to enter the Canadian cannabis space in 2017, when it first invested in Canopy Growth Corp. (TSX: WEED). Constellation increased its stake in Canopy to 37 per cent in August 2018 for a total value of $5 billion.

Shares of Organigram closed at $5.07 Thursday on the Toronto Stock Exchange.

Top image via Organigram


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Jared Gnam on Twitter

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can


As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices


Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance


While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe